During the pandemic, Astellas’ oral prostate cancer drug Xtandi scored an interim nod in England as a “COVID friendly” way to treat men at home instead of in hospitals. With the pandemic easing there, cost watchdogs are backing the drug’s use for thousands of patients, offering the company an edge over its rival Johnson & Johnson. The National… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Vaccine Rollout New Variants Tracker Advertisement Continue reading the main story Supported by Continue reading the main story One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health… Read More »
Business Health Loading the player… The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a… Read More »
The Coronavirus Outbreak liveLatest Updates Maps and Cases Risk Near You Vaccine Rollout New Variants Tracker Advertisement Continue reading the main story Supported by Continue reading the main story Johnson & Johnson’s Vaccine Works Well and May Curb Virus Spread F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of… Read More »